1. A genetic algorithm based global search strategy for population pharmacokinetic/pharmacodynamic model selection. (January 2015) Authors: Sale, Mark; Sherer, Eric A. Journal: British journal of clinical pharmacology Issue: Volume 79:Number 1(2015:Jan.) Page Start: 28 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Artificial Intelligence and Pharmacometrics: Time to Embrace, Capitalize, and Advance?. (5th June 2019) Authors: Chaturvedula, Ayyappa; Calad‐Thomson, Stacie; Liu, Chao; Sale, Mark; Gattu, Nandu; Goyal, Navin Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 8:Number 7(2019) Page Start: 440 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Markov Mixed Effects Modeling Using Electronic Adherence Monitoring Records Identifies Influential Covariates to HIV Preexposure Prophylaxis. (6th December 2016) Authors: Madrasi, Kumpal; Chaturvedula, Ayyappa; Haberer, Jessica E.; Sale, Mark; Fossler, Michael J.; Bangsberg, David; Baeten, Jared M.; Celum, Connie; Hendrix, Craig W. Journal: Journal of clinical pharmacology Issue: Volume 57:Number 5(2017) Page Start: 606 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Population and Noncompartmental Pharmacokinetics of Sodium Oxybate Support Weight‐Based Dosing in Children and Adolescents With Narcolepsy With Cataplexy. Issue 5 (18th April 2020) Authors: Chen, Cuiping; Rosen, Carol L.; Ruoff, Chad; Boyce, Leslie H.; Parvataneni, Rupa; Zomorodi, Katie; Brantley, Scott; Sale, Mark; Plazzi, Giuseppe Journal: Clinical and translational science Issue: Volume 13:Issue 5(2020) Page Start: 932 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Population pharmacokinetic modeling and simulations of berotralstat for prophylactic treatment of attacks of hereditary angioedema. Issue 4 (25th February 2022) Authors: Mathis, Amanda; Sale, Mark; Cornpropst, Melanie; Sheridan, William P.; Ma, Shu Chin Journal: Clinical and translational science Issue: Volume 15:Issue 4(2022) Page Start: 1027 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Population pharmacokinetics and exposure–response modeling for evinacumab in homozygous familial hypercholesterolemia. (13th October 2021) Authors: Pu, Xia; Sale, Mark; Yang, Feng; Zhang, Yi; Davis, John D.; Al‐Huniti, Nidal Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 10:Number 11(2021) Page Start: 1412 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Population pharmacokinetics of ofatumumab in patients with chronic lymphocytic leukemia, follicular lymphoma, and rheumatoid arthritis. (28th January 2014) Authors: Struemper, Herbert; Sale, Mark; Patel, Bela R.; Østergaard, Mikkel; Österborg, Anders; Wierda, William G.; Hagenbeek, Anton; Coiffier, Bertrand; Jewell, Roxanne C. Journal: Journal of clinical pharmacology Issue: Volume 54:Number 7(2014:Jul.) Page Start: 818 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗